Tuberculosis and HIV coinfection and rifampicin-resistant tuberculosis among patients living with HIV in Northern part of West Bengal, India
Background: India is one of the top most country among the high tuberculosis (TB) burden countries and ranks the third highest human immunodeficiency virus (HIV) burden country in the world contributing to 23% of the total global load. Mycobacterium tuberculosis (MTB) and HIV are known to act synerg...
Main Authors: | Tapati Mondal, Abhik Sarkar, Surya Jyati Chaudhuri, Julius Rahaman |
---|---|
Format: | Article |
Language: | English |
Published: |
Manipal College of Medical Sciences, Pokhara
2023-01-01
|
Series: | Asian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/AJMS/article/view/47930 |
Similar Items
-
Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01) -
Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01) -
Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients
by: Pan Yan, et al.
Published: (2023-11-01) -
Trends in the incidence of Rifampicin resistant Mycobacterium tuberculosis infection in northeastern Nigeria
by: Muhammad M. Ibrahim, et al.
Published: (2022-09-01) -
Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey
by: Wagdy Amin, et al.
Published: (2024-02-01)